Zydus Lifesciences gets 4 USFDA observations for Jarod Injectable facility

Zydus will work closely with the USFDA to address and resolve the observations in an expeditious manner

Zydus Lifesciences announced that the United States Food and Drug Administration (USFDA) has completed an inspection of its injectable manufacturing facility located at Jarod, near Vadodara, Gujarat.

The inspection was conducted over a 12-day period, from 25th August to 5th September 2025, and concluded with four observations.

Zydus stated that it will work closely with the USFDA to address and resolve the observations in an expeditious manner.